Literature DB >> 26283740

Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands.

C van der Veer1, M S van Rooijen2, M Himschoot1, H J C de Vries3, S M Bruisten1.   

Abstract

BACKGROUND: Men are not routinely tested for Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) in the Netherlands and, therefore, very few studies have looked into their prevalence and/or role in urogenital complaints in the Dutch male population.
OBJECTIVE: To describe the age-specific prevalence and disease burden of TV and MG, and their co-occurrence with Chlamydia trachomatis (CT), in men attending the sexually transmitted infections (STI) clinic in Amsterdam, the Netherlands.
METHODS: Urine samples and clinical data were collected from 526 men who have sex with women (MSW) and 678 men who have sex with men (MSM) attending the STI clinic. To investigate age as a risk factor, we oversampled older men. Urine samples were tested for TV and MG using molecular tests.
RESULTS: The overall prevalence was 0.5% (6/1204) for TV and 3.1% (37/1204) for MG. Four out of the six TV cases were older than 40 years and all TV cases were MSW. No age trend was observed for MG, nor did MG prevalence differ between MSW and MSM. Co-infections between TV or MG and CT were rare. TV infection did not associate with urogenital symptoms, whereas 5.9% of men reporting urogenital symptoms were infected with MG.
CONCLUSIONS: TV infection was rare in men, asymptomatic and was limited to the heterosexual network. MG infection was relatively common and equally prevalent among MSW and MSM of all ages. Most MG infections remained asymptomatic, however, our results suggest that up to 6% of urogenital complaints could be explained by MG infection. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  INFECTIOUS DISEASES; MALES; NON SPECIFIC URETHIUS

Mesh:

Year:  2015        PMID: 26283740     DOI: 10.1136/sextrans-2015-052118

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  11 in total

1.  Multilocus sequence typing of Trichomonas vaginalis clinical samples from Amsterdam, the Netherlands.

Authors:  C van der Veer; M Himschoot; S M Bruisten
Journal:  BMJ Open       Date:  2016-10-13       Impact factor: 2.692

2.  Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis.

Authors:  Jennifer Gratrix; Sabrina Plitt; LeeAnn Turnbull; Petra Smyczek; Judith Brandley; Ron Scarrott; Prenilla Naidu; Penny Parker; Brenda Blore; Amy Bull; Sandy Shokoples; Lindsay Bertholet; Irene Martin; Max Chernesky; Ron Read; Ameeta Singh
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

Review 3.  Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis.

Authors:  Lukas Baumann; Manuel Cina; Dianne Egli-Gany; Myrofora Goutaki; Florian S Halbeisen; Gian-Reto Lohrer; Hammad Ali; Pippa Scott; Nicola Low
Journal:  Sex Transm Infect       Date:  2018-02-09       Impact factor: 3.519

4.  Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance.

Authors:  Thomas Trevis; Marianne Gossé; Nicola Santarossa; Sepehr Tabrizi; Darren Russell; William John McBride
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

5.  Chlamydia trachomatis bacterial load, estimated by Cq values, in urogenital samples from men and women visiting the general practice, hospital or STI clinic.

Authors:  Juliën N A P Wijers; Christian J P A Hoebe; Geneviève A F S van Liere; Petra F G Wolffs; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

6.  STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.

Authors:  Klaus Jansen; Gyde Steffen; Anja Potthoff; Ann-Kathrin Schuppe; Daniel Beer; Heiko Jessen; Stefan Scholten; Petra Spornraft-Ragaller; Viviane Bremer; Carsten Tiemann
Journal:  BMC Infect Dis       Date:  2020-02-07       Impact factor: 3.090

7.  Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay.

Authors:  Joyce F Braam; David J Hetem; Clarissa E Vergunst; Sophie Kuizenga Wessel; Martijn S van Rooijen; Roel H T Nijhuis; Maarten F Schim van der Loeff; Alje P van Dam; Sylvia M Bruisten
Journal:  PLoS One       Date:  2020-10-20       Impact factor: 3.240

8.  Prevalence of and risk factors for curable sexually transmitted infections on Bubaque Island, Guinea Bissau.

Authors:  Giovanna Cowley; Gregory Milne; Eunice Teixeira da Silva; Jose Nakutum; Amabelia Rodrigues; Hristina Vasileva; David Mabey; Bart Versteeg; Anna Last
Journal:  Sex Transm Infect       Date:  2020-04-28       Impact factor: 3.519

Review 9.  Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men.

Authors:  Olivia T Van Gerwen; Andres F Camino; Jyoti Sharma; Patricia J Kissinger; Christina A Muzny
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 20.999

10.  Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study.

Authors:  Agnès Libois; Marie Hallin; Tania Crucitti; Marc Delforge; Stéphane De Wit
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.